The reasons for this toxicity and the cellular pathways relevant for this process are under debate and many alterations have been reported, including DNA-fragmentation, apoptosis, spindle disorganization and involvement of the chaperone system or diverse prion proteins [ 20, 23, 24, 26].
However, many TM alterations have been described: loss of trabecular cells, fusion of trabecular lamellae and collapse of intertrabecular spaces, increase in extracellular material, and obliteration of the canal have been found to varying degrees around the circumference of eyes with pigment dispersion syndrome and elevated intraocular pressure and in pigmentary glaucoma.
In the past decade many genetic alterations have been discovered that influence tumor growth and spread.
Recently vimentin has evolved as a marker of 'epithelial mesenchymal transdifferentiation' and many molecular alterations have been implicated in this process including Notch, miR-200 and others (Klymkowsky and Savagner, 2009).
Many other blood alterations have been proposed as candidate biomarkers for ALS (Table 5).
Many of these alterations have prognostic impact on the clinical outcome, especially on resistance to chemotherapy and relapse rates [ 1, 2].
In many cases, these alterations have deleterious effects on development and reproductive fitness [69], making it very difficult to obtain animals carrying the desired combination of genotypes.
Among the many alterations that have been detected, L858R missense mutation or in-frame deletion at exon 19 are the most dominant, conferring hyper tyrosine kinase activity and stabilization of protein expression.
Although many candidate genes and CNV alterations have been identified as genetic risk factors, the shortcomings of these findings include low reproducibility, low risk ratio, low penetrance, and lack of disease specificity.
In summary, an extensive database of RNA expression and DNA copy number alterations have been compiled, many of which have been placed in public databases.
As many as 100 molecular or cytogenetic alterations have been associated with AML making it one of the most diverse and challenging forms of human cancer.
